The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Current status and future prospects of pharmacovigilance in Pakistan
|
---|---|
Published in |
Journal of Pharmaceutical Policy and Practice, May 2019
|
DOI | 10.1186/s40545-019-0178-x |
Pubmed ID | |
Authors |
Rabia Hussain, Mohamed Azmi Hassali |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 5 | 31% |
Pakistan | 3 | 19% |
Sweden | 2 | 13% |
Spain | 1 | 6% |
Colombia | 1 | 6% |
Unknown | 4 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 12 | 75% |
Science communicators (journalists, bloggers, editors) | 3 | 19% |
Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 26 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 5 | 19% |
Researcher | 3 | 12% |
Lecturer | 2 | 8% |
Student > Doctoral Student | 2 | 8% |
Other | 1 | 4% |
Other | 4 | 15% |
Unknown | 9 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 27% |
Nursing and Health Professions | 3 | 12% |
Medicine and Dentistry | 2 | 8% |
Business, Management and Accounting | 1 | 4% |
Computer Science | 1 | 4% |
Other | 1 | 4% |
Unknown | 11 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2020.
All research outputs
#2,846,277
of 23,274,744 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#77
of 421 outputs
Outputs of similar age
#61,434
of 351,025 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#2
of 9 outputs
Altmetric has tracked 23,274,744 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 421 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,025 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.